Clinical Trials Browser

Phase 1/2 × Not yet recruiting × Immune Checkpoint Inhibitors × Clear all

NCT05806385 2025-09-09

LOGIC

Phase 1/2 Not yet recruiting

Triple Negative Breast Neoplasms